MCK Insider Trading

Insider Ownership Percentage: 0.11%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $32,683,518.16

McKesson Insider Trading History Chart

This chart shows the insider buying and selling history at McKesson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M$0$20MTotal Insider BuyingTotal Insider Selling

McKesson Share Price & Price History

Current Price: $697.22
Price Change: Price Increase of +2.519 (0.36%)
As of 04/17/2025 04:59 PM ET

This chart shows the closing price history over time for MCK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$697.22Closing price on 04/17/25:

SEC Filings (Institutional Ownership Changes) for McKesson (NYSE:MCK)

85.07% of McKesson stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MCK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.85Bbought$79MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$5B$0$5BTotal InflowsTotal Outflows
McKesson logo
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Read More on McKesson

Today's Range

Now: $697.22
Low: $686.64
High: $702.00

50 Day Range

MA: $650.16
Low: $593.82
High: $716.71

52 Week Range

Now: $697.22
Low: $464.42
High: $728.32

Volume

1,044,943 shs

Average Volume

887,370 shs

Market Capitalization

$87.38 billion

P/E Ratio

31.92

Dividend Yield

0.42%

Beta

0.49

Who are the company insiders with the largest holdings of McKesson?

McKesson's top insider shareholders include:
  1. Brian S Tyler (CEO)
  2. Britt J Vitalone (CFO)
  3. Nancy Avila (EVP)
  4. Thomas L Rodgers (EVP)
  5. Leann B Smith (EVP)
  6. Maria Martinez (Director)
  7. Susan R Salka (Director)
Learn More about top insider investors at McKesson.

Who are the major institutional investors of McKesson?

McKesson's top institutional shareholders include:
  1. GAMMA Investing LLC — 1.91%
  2. Assenagon Asset Management S.A. — 0.19%
  3. Handelsbanken Fonder AB — 0.17%
  4. Wealth Enhancement Advisory Services LLC — 0.15%
  5. Meyer Handelman Co. — 0.09%
  6. Mn Services Vermogensbeheer B.V. — 0.04%
Learn More about top institutional investors of McKesson stock.

Which major investors are selling McKesson stock?

In the last quarter, MCK stock was sold by these institutional investors:
  1. Warther Private Wealth LLC
  2. Chicago Capital LLC
  3. Assenagon Asset Management S.A.
  4. Summit Global Investments
  5. Unigestion Holding SA
  6. CX Institutional
  7. Mn Services Vermogensbeheer B.V.
  8. Tobam
During the previous year, company insiders that have sold McKesson company stock include:
  1. Brian S Tyler (CEO)
  2. Britt J Vitalone (CFO)
  3. Nancy Avila (EVP)
  4. Thomas L Rodgers (EVP)
  5. Leann B Smith (EVP)
  6. Maria Martinez (Director)
Learn More investors selling McKesson stock.

Which major investors are buying McKesson stock?

In the last quarter, MCK stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Handelsbanken Fonder AB
  3. Union Bancaire Privee UBP SA
  4. Vest Financial LLC
  5. Wealth Enhancement Advisory Services LLC
  6. Fourpath Capital Management LLC
  7. SG Americas Securities LLC
  8. Sowell Financial Services LLC